Cite
HARVARD Citation
Andtbacka, R. et al. (n.d.). 3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM. European journal of cancer. pp. S676-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Andtbacka, R. et al. (n.d.). 3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM. European journal of cancer. pp. S676-. [Online].